Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

Transforming Growth Factor-beta 1, human platelets, carrier free, 97%, BT-213CF - TGF-beta1 - J65044 - Alfa Aesar

J65044 Transforming Growth Factor-beta 1, human platelets, carrier free, 97%, BT-213CF

CAS-Nummer
Synonyme
TGF-beta1

Größe Preis ($) Menge Verfügbarkeit
5micrograms 650,00
Zum Warenkorb hinzufügen Zur Angebotsanfrage hinzufügen Artikel anzeigen

Transforming Growth Factor-beta 1, human platelets, carrier free, 97%, BT-213CF

MDL
MFCD00166089

Chemische Eigenschaften

Form
Liquid
Löslichkeit
Fully miscible.

Anwendungen

Transforming Growth Factor-β1 is a multifunctional protein capable of influencing cell proliferation, differentiation, and a variety of cellular functions. TGF-β stimulates the growth of cells of mesenchymal origin, but inhibits growth of hepatocytes, T and B lymphocytes and epithelial cells. TGF-β is known to interact with several agents including EGF, FGF, TGF-α, PDGF, and IL-2. TGF-β is an important mediator of the formation of the extracellular matrix, generally with activities that stimulate the formation of the extracellular matrix and inhibit the degradation of the extracellular matrix. TGF-β is a potent inhibitor of the myogenesis of both skeletal and cardiac muscle cells in vitro. Porcine TGF-β1 is identical in amino acid composition to human TGF-β1.

Bemerkungen

Store away from strong oxidizing agents. Keep container tightly closed. Store in cool, dry conditions in well sealed containers.

Literaturverweise

Oka, Y.; Orth, D.N. Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. J Clin Invest. 1983, 72, (1), 249-259.

Steven B. Nicoll.; Shulamith Radin.; Eric M. Santos.; Rocky S. Tuan.; Paul Ducheyne. In vitro release kinetics of biologically active transforming growth factor-β1 from a novel porous glass carrier ?. Biomaterials. 1997, 18, (12), 853-859.

GHS Gefahren- und Sicherheitshinweise

Gefahrenhinweise (EU): H225-H313-H333-H319

Highly flammable liquid and vapour. May be harmful in contact with skin. May be harmful if inhaled. Causes serious eye irritation.

Sicherheitshinweise: P210-P280a-P240-P303+P361+P353-P305+P351+P338-P501a

Keep away from heat/sparks/open flames/hot surfaces. - No smoking. Wear protective gloves and eye/face protection. Ground/bond container and receiving equipment. IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Dispose of contents/container in accordance with local/regional/national/international regulations.

Weitere Referenzen

Gefahrenklasse
3
Verpackungsgruppe
II
Harmonized Tariff Code
2937.19
TSCA
No

Empfohlen

  • H52512

    4-Fluoro-3-[methoxy(methyl)carbamoyl]benzeneboronic acid, 98%
  • J67317

    CP-31398, 98%
  • H27416

    5-Nitro-2-(n-propylamino)pyridine, 96%
  • L17808

    4-Fluoro-3-formylbenzeneboronic acid, 98+%
  • J64087

    L-Isoleucine 7-amido-4-methylcoumarin trifluoroacetate salt

Kürzlich angesehen

Chemikalien

Life science

Metalle und Stoffe

Katalysatoren

Forschungs- und Laborbedarf